Comparative multi‐omics in female mice reveals tissue‐specific vulnerabilities to chronic alcohol intake
Alcohol, Clinical and Experimental Research · 2026
DOI: 10.1111/acer.70240 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Alcohol, Clinical and Experimental Research, 2026. Verfasst von Craig R G Willis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Software and Analytics, University of Exeter, Exeter, UK. Hauptthemen laut MEDLINE: Muscle, Skeletal, Liver, Alcohol Drinking, Ethanol. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Exeter's Project ADA, NIH HHS, UK Research and Innovation.
Abstract (Originalsprache)
Background
Alcohol‐related liver disease (ALD) and alcohol‐related myopathy are consequences of chronic alcohol use. However, understanding of the associated molecular mechanisms and effective treatments remains limited.
Methods
Multi‐omics were employed to uncover molecular blueprints of liver versus skeletal muscle responses to chronic alcohol exposure, using a preclinical mouse model showing signs of alcohol‐related liver dysregulation (diminished liver phosphatidylcholine‐to‐phosphatidylethanolamine lipid ratio) and alcohol‐related myopathy (reduced muscle mass and strength).
Results
A greater proportion of transcriptomic, proteomic, and metabolomic features were altered by alcohol in liver than muscle, whereas similar proportions of lipid species were affected in both tissues. The liver was significantly enriched for a broad and diverse set of metabolic pathways across molecular layers, while muscle was associated with upregulated inflammatory and matrisome responses and impaired mitochondrial energetics. Lipidome analyses also revealed a novel potential role for altered phospholipid remodeling in the etiology of alcohol‐related myopathy. Finally, computational drug repurposing identified several compounds for therapeutic targeting of alcohol‐induced liver (e.g., saracatinib, GSK126) and muscle (e.g., metformin, trichostatin A) pathophysiology.
Conclusions
Overall, this study provides a list of therapeutic targets and treatments to help expedite the understanding of and countermeasures against ALD and myopathy in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Software and Analytics, University of Exeter, Exeter, UK.
- Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
- Ohio Musculoskeletal and Neurological Institute, Ohio University, Athens, Ohio, USA.
- Honors Tutorial College, Ohio University, Athens, Ohio, USA.
- Institute for Molecular Medicine and Aging, Ohio University, Athens, Ohio, USA.
ORCID-Profile: Craig R G Willis, Muni Swamy Ganjayi, Nathaniel J Szewczyk, Brian C Clark, Cory W Baumann
Förderung
- University of Exeter's Project ADA
- NIH HHS
- UK Research and Innovation
- Osteopathic Heritage Foundation
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Willis, C. R. G., Ganjayi, M. S., Brown, A. M., Moser, S. E., Szewczyk, N. J., Clark, B. C., & Baumann, C. W. (2026). Comparative multi‐omics in female mice reveals tissue‐specific vulnerabilities to chronic alcohol intake. Alcohol, Clinical and Experimental Research. https://doi.org/10.1111/acer.70240
Vancouver
Willis CRG, Ganjayi MS, Brown AM, Moser SE, Szewczyk NJ, Clark BC, et al. Comparative multi‐omics in female mice reveals tissue‐specific vulnerabilities to chronic alcohol intake. Alcohol, Clinical and Experimental Research. 2026. doi:10.1111/acer.70240
BibTeX
@article{Willis2026,
author = {Willis, Craig R G and Ganjayi, Muni Swamy and Brown, Austin M and Moser, Samantha E and Szewczyk, Nathaniel J and Clark, Brian C and Baumann, Cory W},
title = {Comparative multi‐omics in female mice reveals tissue‐specific vulnerabilities to chronic alcohol intake},
journal = {Alcohol, Clinical and Experimental Research},
year = {2026},
doi = {10.1111/acer.70240}
}
EUVIMED